Glenmede Trust’s Pulmatrix PULM Stock Holding History

Glenmede Trust’s Portfolio PULM Stock Details PULM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-110	Closed	-$2K	–	1996
2020 Q3	$2K	Sell	110 -20	-15%	-$509	﹤0.01%	2279
2020 Q2	$4K	Hold	130	–	–	﹤0.01%	2135
2020 Q1	$2K	Hold	130	–	–	﹤0.01%	2867
2019 Q4	$2K	Hold	130	–	–	﹤0.01%	2867
2019 Q3	$2	Hold	130	–	–	﹤0.01%	2864
2019 Q2	$2	Hold	130	–	–	﹤0.01%	2871
2019 Q1	$3	Hold	130	–	–	﹤0.01%	2758
2018 Q4	$6	Hold	130	–	–	﹤0.01%	2484
2018 Q3	$9K	Hold	130	–	–	﹤0.01%	1386
2018 Q2	$12K	Hold	130	–	–	﹤0.01%	1850
2018 Q1	$36K	Hold	130	–	–	﹤0.01%	1754
2017 Q4	$36K	Hold	130	–	–	﹤0.01%	1754
2017 Q3	$53K	Sell	130 -200	-61%	-$81.5K	﹤0.01%	1631
2017 Q2	$229K	Hold	330	–	–	﹤0.01%	1159
2017 Q1	$229K	Hold	330	–	–	﹤0.01%	1159
2016 Q4	$38K	Hold	330	–	–	﹤0.01%	1700
2016 Q3	$108K	Hold	330	–	–	﹤0.01%	1373
2016 Q2	$128K	Hold	330	–	–	﹤0.01%	1306
2016 Q1	$183K	Hold	330	–	–	﹤0.01%	1183
2015 Q4	$277K	Buy	+330	New	+$298K	﹤0.01%	1089

Other funds holding PULM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

HSA

Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Glenmede Trust's PULM Position: Q4 2020 in Review

Glenmede Trust sold out of Pulmatrix (PULM) in Q4 2020, closing a stake of 110 shares — an estimated $2K sold.

Glenmede Trust first reported a position in PULM in Q4 2015 and held it in 20 quarters. The position peaked at $277K in Q4 2015. 26 funds tracked by Wall St. Rank hold PULM as of Q4 2020.

Glenmede Trust reported no remaining Pulmatrix position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 110 Pulmatrix shares in Q4 2020, an estimated $2K.
Glenmede Trust first reported a position in Pulmatrix in Q4 2015 and held it in 20 quarters.
Glenmede Trust's Pulmatrix position peaked at $277K in Q4 2015.
26 funds tracked by Wall St. Rank held Pulmatrix as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.